irisin glp-1 Frontiers Irisin: A Multifaceted Hormone Bridging
Description
This is just a glimpse of the GLP-1 insights available to CivicScience clients

Do not swallow

The anti-inflammatory and anti-obesity properties of GLP-1 RAs as well as their moderating effects on multiple pathobiological pathways in asthma pathogenesis may decrease asthma exacerbations, improve quality of life, and decrease premature death among patients with asthma and co-morbid diabetes or obesity

Why the first non-peptide oral GLP-1 is drawing serious attentionand where caution still applies

AbbVies got Rinvoq and Stelara doing well, Sanofi and Regenerons Dupixent is strong, and Skyrizi keeps growing

November 1, 2023
